You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

apalutamide

Showing 26 - 50 of 123
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Learn About Novel Hormonal Therapies in People With Metastatic

Not yet recruiting
  • Prostatic Neoplasms
  • Novel hormonal therapy
  • New York, New York
    Pfizer Inc
Oct 2, 2023

Prostate Cancer, Metastatic Prostate Cancer Trial in Tampa (Abiraterone, Enzalutamide, Apalutamide)

Recruiting
  • Prostate Cancer
  • Metastatic Prostate Cancer
  • Tampa, Florida
    Moffitt Cancer Center
Feb 21, 2023

Castration-Resistant Prostate Cancer Trial in Las Vegas, Port Jefferson Station (Enzalutamide or Abiraterone or Apalutamid)

Recruiting
  • Castration-Resistant Prostate Cancer
  • Enzalutamide or Abiraterone or Apalutamid
  • Las Vegas, Nevada
  • +1 more
Apr 4, 2022

Prostatic Tumors Trial in Brazil, Colombia, Mexico (Apalutamide, ADT (Standard of Care))

Available
  • Prostatic Neoplasms
  • Apalutamide
  • ADT (Standard of Care)
  • Florianopolis, Brazil
  • +19 more
Aug 2, 2022

Metastatic Prostate Carcinoma, Prostate Adenocarcinoma, Prostate Carcinoma Metastatic in the Bone Trial in Houston (Abiraterone

Active, not recruiting
  • Metastatic Prostate Carcinoma
  • +5 more
  • Abiraterone Acetate
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 26, 2022

High-Risk and Oligometastatic Prostate Cancer Trial (Apalutamide)

Not yet recruiting
  • High-Risk and Oligometastatic Prostate Cancer
  • Apalutamide
  • (no location specified)
Aug 2, 2021

Prostate Cancer Trial in United States (GnRH, Bicalutamide, Salvage radiation)

Active, not recruiting
  • Prostate Cancer
  • San Diego, California
  • +7 more
Mar 7, 2022

Prostate Cancer Metastatic Trial in Omaha, New York (Apalutamide, Abiraterone acetate, Docetaxel)

Active, not recruiting
  • Prostate Cancer Metastatic
  • Apalutamide
  • +3 more
  • Omaha, Nebraska
  • +1 more
Aug 26, 2021

Prostatic Tumors Trial in Austria, Germany (Standard of care, Apalutamide 60Mg Tab)

Recruiting
  • Prostatic Neoplasms
  • Standard of care
  • Apalutamide 60Mg Tab
  • Innsbruck, Austria
  • +24 more
May 5, 2022

Castration Levels of Testosterone, Castration-Resistant Prostate Carcinoma, PSA Progression Trial in San Francisco (Apalutamide,

Recruiting
  • Castration Levels of Testosterone
  • +3 more
  • Apalutamide
  • Stereotactic Body Radiation Therapy
  • San Francisco, California
    University of California, San Francisco
Aug 26, 2021

Physical Function During ARSI Treatment

Recruiting
  • Advanced Prostate Carcinoma
  • androgen receptor signaling inhibitors
  • Chapel Hill, North Carolina
    Lineberger Comprehensive Cancer Center at University of North Ca
Nov 8, 2022

Prostate Cancer Trial in Shatin (Apalutamide, Enzalutamide)

Recruiting
  • Prostate Cancer
  • Shatin, Hong Kong
    Prince of Wales Hospital
Aug 3, 2021

Prostate Cancer Trial in United States (ARN-509, Abiraterone Acetate, Prednisone)

Active, not recruiting
  • Prostate Cancer
  • New Orleans, Louisiana
  • +13 more
Feb 5, 2022

Stage III Prostate Adenocarcinoma AJCC v7, Stage III Prostate Cancer AJCC v7, Stage IV Prostate Adenocarcinoma AJCC v7 Trial in

Completed
Has Results
  • Stage III Prostate Adenocarcinoma AJCC v7
  • +3 more
  • Abiraterone Acetate
  • +5 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Dec 15, 2021

Metastatic Prostate Cancer in Pirkanmaa Hospital District in

Not yet recruiting
  • Metastatic Castration Sensitive Prostate Cancer (mCSPC)
  • Metastatic Castration Resistant Prostate Cancer (mCRPC)
  • (no location specified)
Jan 17, 2023

Prostatic Tumors Trial in China (Apalutamide, Placebo, Androgen-deprivation Therapy (ADT))

Recruiting
  • Prostatic Neoplasms
  • Apalutamide
  • +2 more
  • Beijing, China
  • +29 more
Aug 15, 2022

Metastatic Hormone Sensitive Prostate Cancer Treated With

Not yet recruiting
  • Metastatic Hormone-sensitive Prostate Cancer
  • Innsbruck, Austria
  • +42 more
Jun 5, 2023

Prostate Adenocarcinoma, Prostate Cancer, Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) Trial in Boston (Apalutamide

Not yet recruiting
  • Prostate Adenocarcinoma
  • +2 more
  • Apalutamide [Erleada], darolutamide [Nubeqa], or enzalutamide [Xtandi]
  • Prostate-Specific Membrane Antigen (PSMA) PET/CT Scan
  • Boston, Massachusetts
    Beth Israel Deaconess Medical Center
Jan 4, 2023

Prostate Cancer Trial in La Jolla, Boston, New York (Apalutamide, Leuprolide, Prednisone)

Active, not recruiting
Has Results
  • Prostate Cancer
  • Apalutamide
  • +3 more
  • La Jolla, California
  • +3 more
Sep 1, 2021

Prostate Adenocarcinoma, Stage II Prostate Cancer AJCC v8, Stage IIIA Prostate Cancer AJCC v8 Trial in Los Angeles (drug,

Not yet recruiting
  • Prostate Adenocarcinoma
  • +3 more
  • Apalutamide
  • +7 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Oct 5, 2023

Prostate Cancer Trial in Brazil (Apalutamide, Abiraterone, ADT)

Completed
  • Prostate Cancer
  • Apalutamide
  • +3 more
  • Salvador, Bahia, Brazil
  • +13 more
Jul 5, 2021

Prostate Cancer Trial in Sao Paulo (Goserelin, Prednisone, Abiraterone)

Unknown status
  • Prostate Cancer
  • Sao Paulo, SP, Brazil
    Instituto do Cancer do Estado de Sao Paulo
May 14, 2021

Prostate Cancer Trial (Apalutamide Oral Tablet [Erleada], Placebo)

Not yet recruiting
  • Prostate Cancer
  • Apalutamide Oral Tablet [Erleada]
  • Placebo
  • (no location specified)
Jan 11, 2022

Cancer of Prostate Trial in Belgium (Apalutamide, Leuprorelin Acetate 45Mg Powder for Injection Suspension Vial, Goserelin

Recruiting
  • Cancer of Prostate
  • Apalutamide
  • +4 more
  • Aalst, Belgium
  • +8 more
Aug 4, 2021

Prostate Cancer Trial in France (Apalutamide, Salvage radiotherapy (SRT), Luteinising Hormone Releasing Hormone agonist (LHRHa))

Recruiting
  • Prostate Cancer
  • Apalutamide
  • +2 more
  • Albi, France
  • +14 more
Sep 22, 2021